| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |